Clinical recognition of meningococcal disease in children and adolescents
- PMID: 16458763
- DOI: 10.1016/S0140-6736(06)67932-4
Clinical recognition of meningococcal disease in children and adolescents
Abstract
Background: Meningococcal disease is a rapidly progressive childhood infection of global importance. To our knowledge, no systematic quantitative research exists into the occurrence of symptoms before admission to hospital.
Methods: Data were obtained from questionnaires answered by parents and from primary-care records for the course of illness before admission to hospital in 448 children (103 fatal, 345 non-fatal), aged 16 years or younger, with meningococcal disease. In 373 cases, diagnosis was confirmed with microbiological techniques. The rest of the children were included because they had a purpuric rash, and either meningitis or evidence of septicaemic shock. Results were standardised to UK case-fatality rates.
Findings: The time-window for clinical diagnosis was narrow. Most children had only non-specific symptoms in the first 4-6 h, but were close to death by 24 h. Only 165 (51%) children were sent to hospital after the first consultation. The classic features of haemorrhagic rash, meningism, and impaired consciousness developed late (median onset 13-22 h). By contrast, 72% of children had early symptoms of sepsis (leg pains, cold hands and feet, abnormal skin colour) that first developed at a median time of 8 h, much earlier than the median time to hospital admission of 19 h.
Interpretation: Classic clinical features of meningococcal disease appear late in the illness. Recognising early symptoms of sepsis could increase the proportion of children identified by primary-care clinicians and shorten the time to hospital admission. The framework within which meningococcal disease is diagnosed should be changed to emphasise identification of these early symptoms by parents and clinicians.
Comment in
-
Changing the diagnostic framework of meningococcal disease.Lancet. 2006 Feb 4;367(9508):371-2. doi: 10.1016/S0140-6736(06)67934-8. Lancet. 2006. PMID: 16458743 No abstract available.
-
Clinical recognition of meningococcal disease.Lancet. 2006 Apr 29;367(9520):1394-5; author reply 1395-6. doi: 10.1016/S0140-6736(06)68607-8. Lancet. 2006. PMID: 16650642 No abstract available.
-
Clinical recognition of meningococcal disease.Lancet. 2006 Apr 29;367(9520):1394; author reply 1395-6. doi: 10.1016/S0140-6736(06)68606-6. Lancet. 2006. PMID: 16650643 No abstract available.
-
Clinical recognition of meningococcal disease.Lancet. 2006 Apr 29;367(9520):1395; author reply 1395-6. doi: 10.1016/S0140-6736(06)68608-X. Lancet. 2006. PMID: 16650645 No abstract available.
Similar articles
-
Which early 'red flag' symptoms identify children with meningococcal disease in primary care?Br J Gen Pract. 2011 Mar;61(584):e97-104. doi: 10.3399/bjgp11X561131. Br J Gen Pract. 2011. PMID: 21375891 Free PMC article.
-
Early management of meningococcal disease.Commun Dis Rep CDR Rev. 1995 Aug 18;5(9):R135-7. Commun Dis Rep CDR Rev. 1995. PMID: 7670577
-
Fifteen-minute consultation: Symptoms and signs of meningococcal disease.Arch Dis Child Educ Pract Ed. 2020 Aug;105(4):200-203. doi: 10.1136/archdischild-2019-317722. Epub 2019 Oct 16. Arch Dis Child Educ Pract Ed. 2020. PMID: 31619453 Review.
-
Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002.Epidemiol Infect. 2006 Feb;134(1):103-10. doi: 10.1017/S0950268805004553. Epidemiol Infect. 2006. PMID: 16409656 Free PMC article.
-
Early clinical clues to meningococcaemia.Med J Aust. 2003 Feb 3;178(3):134-7. doi: 10.5694/j.1326-5377.2003.tb05106.x. Med J Aust. 2003. PMID: 12558487 Review.
Cited by
-
Epidemiology of invasive meningococcal disease, Japan, 2013 to 2023.Euro Surveill. 2024 Nov;29(46):2400136. doi: 10.2807/1560-7917.ES.2024.29.46.2400136. Euro Surveill. 2024. PMID: 39544146 Free PMC article.
-
Exploring the Health-Related Quality of Life and the Lived Experience of Adolescents Following Invasive Meningococcal Disease.Healthcare (Basel). 2024 May 24;12(11):1075. doi: 10.3390/healthcare12111075. Healthcare (Basel). 2024. PMID: 38891151 Free PMC article.
-
Effect of Respiratory Failure on Peripheral and Organ Perfusion Markers in Severe COVID-19: A Prospective Cohort Study.J Clin Med. 2024 Jan 15;13(2):469. doi: 10.3390/jcm13020469. J Clin Med. 2024. PMID: 38256603 Free PMC article.
-
An Overview of Meningococcal Disease's Recent Diagnostic and Treatment Model.Cureus. 2023 Nov 8;15(11):e48509. doi: 10.7759/cureus.48509. eCollection 2023 Nov. Cureus. 2023. PMID: 38073961 Free PMC article. Review.
-
Meningococcal Disease in the Post-COVID-19 Era: A Time to Prepare.Infect Dis Ther. 2023 Dec;12(12):2649-2663. doi: 10.1007/s40121-023-00888-w. Epub 2023 Dec 4. Infect Dis Ther. 2023. PMID: 38048020 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
